The association between body composition and self-reported co-morbidity in subjects with chronic obstructive pulmonary disease

Erica P. A. Rutten, Per S. Bakke, Sreekumar G. Pillai, Scott Wagers, Thomas B. Grydeland, Amund Gulsvik, Emiel F. M. Wouters

Center of Expertise for Chronic Organ Failure (Ciro), Horn, The Netherlands.
Genetics, GlaxoSmithKline R&D, Raleigh, USA.
Section of Thoracic Medicine, Institute of Medicine, University of Bergen, Bergen, Norway.

DOI: 10.4236/ojim.2012.22019                

Abstract

Background: Differences in body composition are extensively investigated in subjects with COPD as low muscle mass was independently associated with increased morbidity and mortality. Also cardio-vascular co-morbidity is often reported in COPD and the contribution of fat mass in COPD related co-morbidity is gaining interest. We hypothesized that the prevalence of low muscle mass and high fat mass is higher in subjects with COPD compared to a group of current and former smokers without COPD, which result in higher reported cardiovascular co-morbidity in the COPD group. Methods: In 954 subjects with COPD and 955 subjects without COPD, body composition was assessed by bio-electrical impedance analysis and information on self-reported co-morbidity was collected. Participants were stratified for low fat free mass index and high fat mass index (resp. fat free mass index <10th percentile="" and="" fat="" mass="" index="">50th percentile of the subjects without COPD). Results: Subjects with COPD were more likely to have low fat free mass index than current and former smokers without COPD. The prevalence of high fat mass index was comparable between the groups. The percentage of self-reported co-morbidity was higher in subjects with COPD, but only reports of myocardial infarction were disease specific. Conclusion: Low fat free mass index was more common in COPD, but the prevalence of high fat mass index was comparable between subjects with and without COPD. Nevertheless, subjects with COPD reported more myocardial infarction, implying that other factors than the amount of fat mass are involved in the increased co-morbidity in COPD.

Keywords

Co-Morbidity; Fat Free Mass; Fat Mass

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Lindberg, A., Larsson, L.G., Ronmark, E. and Lundback, B. (2011) Co-morbidity in mild-to-moderate COPD: Comparison to normal and restrictive lung function. Chronic Obstructive Pulmonary Disease, 8, 421-428. doi:10.3109/15412555.2011.629858
[2]	Agusti, A., Calverley, P.M., Celli, B., Coxson, H.O., Edwards, L.D., Lomas, D.A., et al. (2010) Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respiratory Research, 11, 122.
[3]	Mostert, R., Goris, A., Weling-Scheepers, C., Wouters, E.F. and Schols, A.M. (2000) Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respiratory Medicine, 2000, 94, 859-867. doi:10.1053/rmed.2000.0829
[4]	Schols, A.M., Broekhuizen, R., Weling-Scheepers, C.A. and Wouters, E.F. (2005) Body composition and mortality in chronic obstructive pulmonary disease. The American Journal of Clinical Nutrition, 82, 53-59.
[5]	Vermeeren, M.A., Creutzberg, E.C., Schols, A.M., Postma, D.S., Pieters, W.R., Roldaan, A.C., et al. (2006) Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respiratory Medicine, 100, 1349-1355. doi:10.1016/j.rmed.2005.11.023
[6]	Vestbo, J., Prescott, E., Almdal, T., Dahl, M., Nordestgaard, B.G., Andersen, T., et al. (2006) Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: Findings from the Copenhagen City Heart Study. American Journal of Respiratory and Critical Care Medicine, 173, 79-83. doi:10.1164/rccm.200505-969OC
[7]	Van Den Borst, B., Koster, A., Yu, B., Gosker, H.R., Meibohm, B., Bauer, D.C., et al. (2011) Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax, 66, 961-969. doi:10.1136/thoraxjnl-2011-200010
[8]	Poulain, M., Doucet, M., Drapeau, V., Fournier, G., Tremblay, A., Poirier, P., et al. (2008) Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Chronic Respiratory Disease, 5, 35-41. doi:10.1177/1479972307087205
[9]	Van Den Borst, B., Gosker, H.R., Wesseling, G., De Jager, W., Hellwig, V.A., Snepvangers, F.J., et al. (2011) Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease. The American Journal of Clinical Nutrition, 94, 1504-1512. doi:10.3945/ajcn.111.023911
[10]	De Luis, D.A., Sagrado, M.G., Conde, R., Aller, R., Izaola, O. and Romero, E. (2007) Circulating adipocytokines in obese nondiabetic patients in relationship with cardiovascular risk factors, anthropometry and resting-energy expenditure. Annals of Nutrition and Metabolism, 51, 416-420. doi:10.1159/000111160
[11]	Sin, D.D. and Man, S.F. (2003) Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation, 107, 1514-1519. doi:10.1161/01.CIR.0000056767.69054.B3
[12]	Zhu, G., Warren, L., Aponte, J., Gulsvik, A., Bakke, P., Anderson, W.H., et al. (2007) The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. American Journal of Respiratory and Critical Care Medicine, 176, 167-173. doi:10.1164/rccm.200611-1723OC
[13]	Gulsvik, A., Tosteson, T., Bakke, P., Humerfelt, S., Weiss, S.T. and Speizer, F.E. (2001) Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway. Clinical Physiology, 21, 648-660. doi:10.1046/j.1365-2281.2001.00377.x
[14]	Kauffmann, F. (2007) SERPINE2 and COPD. American Journal of Respiratory and Critical Care Medicine, 176, 725-726.
[15]	Eagan, T.M., Gulsvik, A., Eide, G.E. and Bakke, P.S. (2004) Remission of respiratory symptoms by smoking and occupational exposure in a cohort study. European Respiratory Journal, 23, 589-594. doi:10.1183/09031936.04.00041204
[16]	Brogger, J., Eagan, T., Eide, G.E., Bakke, P. and Gulsvik, A. (2004) Bias in retrospective studies of trends in asthma incidence. European Respiratory Journal, 23, 281-286. doi:10.1183/09031936.03.00041103
[17]	Rabe, K.F., Beghe, B., Luppi, F. and Fabbri, L.M. (2007) Update in chronic obstructive pulmonary disease 2006. American Journal of Respiratory and Critical Care Medicine, 175, 1222-1232. doi:10.1164/rccm.200704-586UP
[18]	Dey, D.K., Bosaeus, I., Lissner, L. and Steen, B. (2003) Body composition estimated by bioelectrical impedance in the Swedish elderly. Development of population-based prediction equation and reference values of fat-free mass and body fat for 70- and 75-y olds. European Journal of Clinical Nutrition, 57, 909-916. doi:10.1038/sj.ejcn.1601625
[19]	Rutten, E.P.A., Spruit, M.A. and Wouters, E.F.M. (2010) Critical view on diagnosing muscle wasting by single-frequency bio-eletrical impedance in COPD. Respiratory Medicine, 104, 91-98. doi:10.1016/j.rmed.2009.07.004
[20]	Gosker, H.R., Kubat, B., Schaart, G., Van Der Vusse, G.J., Wouters, E.F. and Schols, A.M. (2003) Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease. European Respiratory Journal, 22, 280-285. doi:10.1183/09031936.03.00012803
[21]	Bridevaux, P.O., Gerbase, M.W., Schindler, C., Felber, D.D., Curjuric, I., Dratva, J., et al. (2009) Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD. European Respiratory Journal, 34, 332-339. doi:10.1183/09031936.00162608
[22]	Breyer, M.K., Rutten, E.P., Vernooy, J.H., Spruit, M.A., Dentener, M.A., Van Der Kallen, C., et al. (2011) Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): A pivotal role of leptin. Respiratory Medicine, 105, 1046-1053. doi:10.1016/j.rmed.2011.02.001